Skip to main content
Top
Published in: Abdominal Radiology 11/2020

01-11-2020 | CT of the Thorax | Interventional Radiology

CT-guided cryoablation of renal cancer: radiation burden and the associated risk of secondary cancer from procedural- and follow-up imaging

Authors: Jens Borgbjerg, Thóra Bylling, Gratien Andersen, Jesper Thygesen, Anders Mikkelsen, Tommy K. Nielsen

Published in: Abdominal Radiology | Issue 11/2020

Login to get access

Abstract

Objectives

To estimate radiation dose and the associated risk of secondary cancer risk related to percutaneous cryoablation (PCA) and follow-up imaging in a cohort of patients treated for small renal masses (SRMs).

Methods

A total of 149 patients underwent PCA for a SRM at our institution. Based on CT dose reports, we calculated the mean effective dose for a CT-guided PCA procedure and post-ablative follow-up CT. Applying follow-up recommendations by a multidisciplinary expert panel, we calculated the total radiation dose for the PCA procedure and the CT surveillance program corresponding to a minimal and preferable follow-up regime (5-year vs 10-year). Estimates of the lifetime attributable cancer risk for different age groups were calculated based on the cumulative effective dose based on the latest BEIR VII report.

Results

Total dose for the PCA treatment and follow-up CTs amounted to 174 and 294 mSv for a minimal and preferable protocol, respectively. Follow-up CTs accounted for the majority of the total effective dose for the minimal and preferable protocol (89% vs 94%). CT fluoroscopy contributed only to a limited amount of the total radiation dose for the minimal and preferable protocol (1.8% vs 1.1%). A 70-year-old male undergoing PCA treatment has a lifetime attributable cancer risk of 0.8% (1 in 131) when completing the preferable follow-up protocol. The same regimen in a 30-year-old female results in a lifetime attributable risk of cancer of 3.4% (1 in 29).

Conclusion

Radiation dose and the associated risk of secondary cancer are high for patients with SRMs undergoing PCA and post-ablative follow-up imaging in particular in younger patients. Radiation exposure in the PCA procedure itself accounts for only a limited amount of the total radiation. Radiologists and clinicians must strive to implement radiation dose saving measures especially with respect to the follow-up regime.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gill, I. S., Aron, M., Gervais, D. A. & Jewett, M. A. S. Clinical practice. Small renal mass. N. Engl. J. Med. 362, 624–634 (2010). Gill, I. S., Aron, M., Gervais, D. A. & Jewett, M. A. S. Clinical practice. Small renal mass. N. Engl. J. Med. 362, 624–634 (2010).
2.
go back to reference Breen, D. J., King, A. J., Patel, N., Lockyer, R. & Hayes, M. Image-guided Cryoablation for Sporadic Renal Cell Carcinoma: Three- and 5-year Outcomes in 220 Patients with Biopsy-proven Renal Cell Carcinoma. Radiology 289, 554–561 (2018).CrossRef Breen, D. J., King, A. J., Patel, N., Lockyer, R. & Hayes, M. Image-guided Cryoablation for Sporadic Renal Cell Carcinoma: Three- and 5-year Outcomes in 220 Patients with Biopsy-proven Renal Cell Carcinoma. Radiology 289, 554–561 (2018).CrossRef
3.
go back to reference Aoun, H. D. et al. Percutaneous Cryoablation of Renal Tumors: Is It Time for a New Paradigm Shift? J. Vasc. Interv. Radiol. 28, 1363–1370 (2017).CrossRef Aoun, H. D. et al. Percutaneous Cryoablation of Renal Tumors: Is It Time for a New Paradigm Shift? J. Vasc. Interv. Radiol. 28, 1363–1370 (2017).CrossRef
4.
go back to reference Grand, D., Dupuy, D., Mayo-Smith, W. & Iannuccilli, J. Percutaneous Ablation for Small Renal Masses—Imaging Follow-Up. Seminars in Interventional Radiology vol. 31 050–063 (2014).CrossRef Grand, D., Dupuy, D., Mayo-Smith, W. & Iannuccilli, J. Percutaneous Ablation for Small Renal Masses—Imaging Follow-Up. Seminars in Interventional Radiology vol. 31 050–063 (2014).CrossRef
5.
go back to reference Okhunov, Z. et al. Salvage Percutaneous Cryoablation for Locally Recurrent Renal-Cell Carcinoma After Primary Cryoablation. J. Endourol. 30, 632–637 (2016).CrossRef Okhunov, Z. et al. Salvage Percutaneous Cryoablation for Locally Recurrent Renal-Cell Carcinoma After Primary Cryoablation. J. Endourol. 30, 632–637 (2016).CrossRef
6.
go back to reference Zondervan, P. J. et al. Follow-up after focal therapy in renal masses: an international multidisciplinary Delphi consensus project. World Journal of Urology vol. 34 1657–1665 (2016).CrossRef Zondervan, P. J. et al. Follow-up after focal therapy in renal masses: an international multidisciplinary Delphi consensus project. World Journal of Urology vol. 34 1657–1665 (2016).CrossRef
7.
go back to reference Brenner, D. J. Slowing the increase in the population dose resulting from CT scans. Radiat. Res. 174, 809–815 (2010).CrossRef Brenner, D. J. Slowing the increase in the population dose resulting from CT scans. Radiat. Res. 174, 809–815 (2010).CrossRef
8.
go back to reference Kanal, K. M. et al. U.S. Diagnostic Reference Levels and Achievable Doses for 10 Adult CT Examinations. Radiology 284, 120–133 (2017). Kanal, K. M. et al. U.S. Diagnostic Reference Levels and Achievable Doses for 10 Adult CT Examinations. Radiology 284, 120–133 (2017).
9.
go back to reference Huda, W., Ogden, K. M. & Khorasani, M. R. Converting dose-length product to effective dose at CT. Radiology 248, 995–1003 (2008).CrossRef Huda, W., Ogden, K. M. & Khorasani, M. R. Converting dose-length product to effective dose at CT. Radiology 248, 995–1003 (2008).CrossRef
10.
go back to reference Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation & National Research Council. Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII _ Phase 2. (National Academies Press, 2006). Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation & National Research Council. Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII _ Phase 2. (National Academies Press, 2006).
12.
go back to reference Fryar, C. D., Kruszon-Moran, D., Gu, Q. & Ogden, C. L. Mean Body Weight, Height, Waist Circumference, and Body Mass Index Among Adults: United States, 1999–2000 Through 2015–2016. Natl. Health Stat. Report. 1–16 (2018). Fryar, C. D., Kruszon-Moran, D., Gu, Q. & Ogden, C. L. Mean Body Weight, Height, Waist Circumference, and Body Mass Index Among Adults: United States, 1999–2000 Through 2015–2016. Natl. Health Stat. Report. 1–16 (2018).
13.
go back to reference Elster, A. D. Effective Doses in Radiology and Diagnostic Nuclear Medicine: A Catalog. Yearbook of Diagnostic Radiology vol. 2010 214–217 (2010).CrossRef Elster, A. D. Effective Doses in Radiology and Diagnostic Nuclear Medicine: A Catalog. Yearbook of Diagnostic Radiology vol. 2010 214–217 (2010).CrossRef
14.
go back to reference Atkins, M. B. & Tannir, N. M. Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma. Cancer Treat. Rev. 70, 127–137 (2018).CrossRef Atkins, M. B. & Tannir, N. M. Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma. Cancer Treat. Rev. 70, 127–137 (2018).CrossRef
15.
go back to reference Sullivan, C. J. et al. Radiation exposure from diagnostic imaging in young patients with testicular cancer. Eur. Radiol. 25, 1005–1013 (2015).CrossRef Sullivan, C. J. et al. Radiation exposure from diagnostic imaging in young patients with testicular cancer. Eur. Radiol. 25, 1005–1013 (2015).CrossRef
16.
go back to reference Sun, M. et al. Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management. Eur. Urol. 65, 235–241 (2014).CrossRef Sun, M. et al. Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management. Eur. Urol. 65, 235–241 (2014).CrossRef
17.
go back to reference Lin, Y.-K., Gettle, L. & Raman, J. D. Significant variability in 10-year cumulative radiation exposure incurred on different surveillance regimens after surgery for pT1 renal cancers: yet another reason to standardize protocols? BJU Int. 111, 891–896 (2013).CrossRef Lin, Y.-K., Gettle, L. & Raman, J. D. Significant variability in 10-year cumulative radiation exposure incurred on different surveillance regimens after surgery for pT1 renal cancers: yet another reason to standardize protocols? BJU Int. 111, 891–896 (2013).CrossRef
18.
go back to reference Liaw, C. W., Winoker, J. S. & Mehrazin, R. Imaging Protocols for Active Surveillance in Renal Cell Carcinoma. Curr. Urol. Rep. 19, 81 (2018).CrossRef Liaw, C. W., Winoker, J. S. & Mehrazin, R. Imaging Protocols for Active Surveillance in Renal Cell Carcinoma. Curr. Urol. Rep. 19, 81 (2018).CrossRef
19.
go back to reference Brenner, D. J. & Hall, E. J. Cancer risks from CT scans: now we have data, what next? Radiology 265, 330–331 (2012).CrossRef Brenner, D. J. & Hall, E. J. Cancer risks from CT scans: now we have data, what next? Radiology 265, 330–331 (2012).CrossRef
20.
go back to reference Cacciamani, G., Fay, C., Park, D., Alotaibi, M. & Gill, I. S. Active Surveillance for Small Renal Masses in Young Patients. Eur Urol Focus 2, 569–571 (2016).CrossRef Cacciamani, G., Fay, C., Park, D., Alotaibi, M. & Gill, I. S. Active Surveillance for Small Renal Masses in Young Patients. Eur Urol Focus 2, 569–571 (2016).CrossRef
21.
go back to reference Kim, D. K., Won, J. Y. & Park, S. Y. Percutaneous cryoablation for renal cell carcinoma using ultrasound-guided targeting and computed tomography-guided ice-ball monitoring: radiation dose and short-term outcomes. Acta Radiologica 028418511879817 (2018) doi:10.1177/0284185118798175. Kim, D. K., Won, J. Y. & Park, S. Y. Percutaneous cryoablation for renal cell carcinoma using ultrasound-guided targeting and computed tomography-guided ice-ball monitoring: radiation dose and short-term outcomes. Acta Radiologica 028418511879817 (2018) doi:10.1177/0284185118798175.
22.
go back to reference Eisenberg, J. D. et al. Radiation Exposure From CT-Guided Ablation of Renal Masses: Effects on Life Expectancy. American Journal of Roentgenology vol. 204 335–342 (2015).CrossRef Eisenberg, J. D. et al. Radiation Exposure From CT-Guided Ablation of Renal Masses: Effects on Life Expectancy. American Journal of Roentgenology vol. 204 335–342 (2015).CrossRef
23.
go back to reference Leng, S. et al. Radiation dose reduction for CT-guided renal tumor cryoablation. AJR Am. J. Roentgenol. 196, W586–91 (2011).CrossRef Leng, S. et al. Radiation dose reduction for CT-guided renal tumor cryoablation. AJR Am. J. Roentgenol. 196, W586–91 (2011).CrossRef
24.
go back to reference Martin, C. J. & Sookpeng, S. Setting up computed tomography automatic tube current modulation systems. J. Radiol. Prot. 36, R74–R95 (2016).CrossRef Martin, C. J. & Sookpeng, S. Setting up computed tomography automatic tube current modulation systems. J. Radiol. Prot. 36, R74–R95 (2016).CrossRef
25.
go back to reference Willemink, M. J. & Noël, P. B. The evolution of image reconstruction for CT—from filtered back projection to artificial intelligence. European Radiology vol. 29 2185–2195 (2019).CrossRef Willemink, M. J. & Noël, P. B. The evolution of image reconstruction for CT—from filtered back projection to artificial intelligence. European Radiology vol. 29 2185–2195 (2019).CrossRef
26.
go back to reference Muangman, N., Maitreesorrasan, N. & Totanarungroj, K. Comparison of low dose and standard dose MDCT in detection of metastatic pulmonary nodules. J. Med. Assoc. Thai. 94, 215–223 (2011).PubMed Muangman, N., Maitreesorrasan, N. & Totanarungroj, K. Comparison of low dose and standard dose MDCT in detection of metastatic pulmonary nodules. J. Med. Assoc. Thai. 94, 215–223 (2011).PubMed
28.
go back to reference Dauer, L. T. et al. Review and evaluation of updated research on the health effects associated with low-dose ionising radiation. Radiat. Prot. Dosimetry 140, 103–136 (2010).CrossRef Dauer, L. T. et al. Review and evaluation of updated research on the health effects associated with low-dose ionising radiation. Radiat. Prot. Dosimetry 140, 103–136 (2010).CrossRef
29.
go back to reference Shah, D. J., Sachs, R. K. & Wilson, D. J. Radiation-induced cancer: a modern view. Br. J. Radiol. 85, e1166–73 (2012).CrossRef Shah, D. J., Sachs, R. K. & Wilson, D. J. Radiation-induced cancer: a modern view. Br. J. Radiol. 85, e1166–73 (2012).CrossRef
Metadata
Title
CT-guided cryoablation of renal cancer: radiation burden and the associated risk of secondary cancer from procedural- and follow-up imaging
Authors
Jens Borgbjerg
Thóra Bylling
Gratien Andersen
Jesper Thygesen
Anders Mikkelsen
Tommy K. Nielsen
Publication date
01-11-2020
Publisher
Springer US
Published in
Abdominal Radiology / Issue 11/2020
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-020-02527-1

Other articles of this Issue 11/2020

Abdominal Radiology 11/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.